Blog Verité

Ukrainian charities and companies supplying the war-torn country’s military warn that problems are growing as Polish truck drivers show no sign of ending a border blockade that has stretched past a month.

Ukrainian charities and companies supplying the war-torn country’s military warn that problems are growing as Polish truck drivers show no sign of ending a border blockade that has stretched past a month.

Hamas brutality on Oct 7 ‘can never justify’ the ‘humanitarian catastrophe’ in Gaza, UN secretary-general says  Fox News Israel-Hamas war: UN ceasefire vote vetoed by US as fighting continues in Gaza | LiveNOW form FOX  LiveNOW from FOX 3 PM ET: Battles

Trump Takes 2024 Lead as Biden Approval Hits New Low, WSJ Poll Finds – WSJ  The Wall Street Journal

Shohei Ohtani has set a financial record to go along with his singular on-field performance, getting a record $700 million to make a 30-mile move up Interstate 5 to the Los Angeles Dodgers.

State Department circumvents Congress, approves $106 million sale of tank ammo to Israel  CBS News State Department Bypasses Congress to Approve Israel’s Order for Tank Ammunition  The New York Times Biden administration uses emergency authority to sell tank shells to Israel  The Guardian

Shohei Ohtani won’t be leaving Southern California. Though he’ll be able to buy a much bigger house, if he so chooses. Or Catalina Island. Ohtani, the generational two-way player from Japan who won two of the past three American League

In our news wrap Saturday, the Texas Supreme Court temporarily blocked a lower court’s decision to allow a pregnant woman whose fetus has a fatal diagnosis to get an abortion, Israel hit targets across Gaza as its war with Hamas

In our news wrap Saturday, the Texas Supreme Court temporarily blocked a lower court’s decision to allow a pregnant woman whose fetus has a fatal diagnosis to get an abortion, Israel hit targets across Gaza as its war with Hamas

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale